FAIM1 Polyclonal Antibody

The protein encoded by this gene protects against death receptor-triggered apoptosis and regulates B-cell signaling and differentiation. Several transcript variants encoding different isoforms have been found for this gene.

The FAIM1 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of Fas apoptotic inhibitory molecule 1 (FAIM1) protein. This antibody is produced using advanced immunization techniques and exhibits exceptional affinity and selectivity towards FAIM1.

FAIM1 is a crucial regulator of apoptosis, playing a pivotal role in the modulation of cell survival and death pathways. It acts as an inhibitor of Fas-mediated apoptosis, thereby promoting cell survival and preventing premature cell death. Dysregulation of FAIM1 expression has been implicated in various pathological conditions, including cancer, autoimmune diseases, and neurodegenerative disorders.

The FAIM1 Polyclonal Antibody is meticulously validated for its specificity and sensitivity through various experimental approaches, including Western blotting, immunohistochemistry, and immunofluorescence. It demonstrates minimal cross-reactivity with other related proteins, ensuring accurate and reliable results.

This antibody is supplied as a liquid formulation, allowing for easy and convenient handling. It is provided in a ready-to-use format, eliminating the need for time-consuming and complex preparation steps. The FAIM1 Polyclonal Antibody is suitable for use in diverse research applications, including but not limited to, protein expression analysis, cellular localization studies, and functional characterization of FAIM1.

With its exceptional performance and reliability, the FAIM1 Polyclonal Antibody is an indispensable tool for researchers and scientists working in the fields of cell biology, immunology, and molecular biology. Its high specificity and sensitivity make it an ideal choice for elucidating the intricate mechanisms underlying apoptosis regulation and exploring potential therapeutic targets for various diseases.